Cancer News, Treatment and Research

Learn about how Oncimmune, a company devoted to early cancer detection, engages individuals through Facebook and other social media tools. Oncimmune® (USA) LLC has a single goal: To advance early cancer detection to the greatest extent possible using autoantibody assay technology through the Early Cancer Detection Test. To achieve this goal, we will strive to: *Make the test available to at-risk individuals through their health care provider. *Meet the highest levels of production and laboratory testing standards and ensure we meet or exceed CLIA requirements and standards. *Continue developing EarlyCDT® for a wide range of cancers. *Support university-based and other research efforts in autoantibody assay technology through The Centre of Excellence for Autoimmunity in Cancer (CEAC) at the University of Nottingham (UK). *Provide value-added services and information to our clients and cancer advocacy groups to promote and support cancer prevention and early detection. For more information, visit www.HelloHaveYouHeard.com.